Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Change in Receivables (2021)

Medicinova (MNOV) has disclosed Change in Receivables for 2 consecutive years, with $4.0 million as the latest value for Q1 2021.

  • On a quarterly basis, Change in Receivables changed N/A to $4.0 million in Q1 2021 year-over-year; TTM through Mar 2021 was -$12.0 million, a N/A change, with the full-year FY2014 number at -$6.0 million, down 200.0% from a year prior.
  • Change in Receivables was $4.0 million for Q1 2021 at Medicinova, up from -$10.0 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $4.0 million in Q1 2021 to a low of $4.0 million in Q1 2021.